Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 113 M— — Research & development 26 M— — Operating income 139 M-4 M — Non-Operating Income, Total 36 M— — Interest expense, net of interest capitalized 2 M— — Non-Operating Income, excl. Interest Expenses -2 M— — Unusual income/expense 36 M— — Pretax income 173 M647 M — Equity in earnings —— — Taxes 182 M138 M — Non-controlling/minority interest 26 M— — After tax other income/expense —— — Net income before discontinued operations 35 M509 M — Discontinued operations —— — Net income 35 M509 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 35 M509 M — Basic earnings per share (Basic EPS) —— — Diluted earnings per share (Diluted EPS) —3.2 — Average basic shares outstanding —158.7 M — Diluted shares outstanding —158.9 M — EBITDA 221 M— — EBIT 171 M— — Cost of revenue 659 M— — Other cost of goods sold —— — Depreciation & amortization (cash flow) 50 M4 M —